The Effect of a Novel Joint Distraction Knee Orthosis for Treating Medial Knee Osteoarthritis

Overseen By Evan Eckersley

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: Icarus Medical Innovations

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: Unknown

What You Need to Know Before You Apply

What is the purpose of this trial?

The Effect of a Novel Joint Distraction Knee Orthosis for Treating Medial Knee Osteoarthritis

Are You a Good Fit for This Trial?

Inclusion Criteria

* Adults aged 30-70, as significant knee OA is very common for people under 30, and would be more likely correlated to trauma.

* Able to ambulate with or without assistive devices

* Body-mass index (BMI) under 35. This is to minimize the effect of the variable of how the brace fits on the patient. The finding of pain relief will extrapolate to any BMI.

What Are the Treatments Tested in This Trial?

How Is the Trial Designed?

Group I: The Effect of a Novel Joint Distraction Knee Orthosis for Treating Medial Knee Osteoarthritis Experimental Treatment 1 Intervention

Patients experiencing unicompartment (medial or lateral) osteoarthritis will receive Icarus Adonis Joint Distraction brace. Patients will wear the brace for 12 weeks and document how often they wear the brace and their pain scores. Patients will fill out outcome surveys at 2, 4, 6, 8, and 12 weeks.

Who Is Running the Clinical Trial?

Icarus Medical Innovations

Lead Sponsor